There were 1,668 press releases posted in the last 24 hours and 314,898 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300 Jupiter Wellness Inc. (NASDAQ: JUPW)

TO:
JUPW
Jupiter Wellness, Inc
561-244-7100

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image